In patients on chronic warfarin therapy, the INR should be closely monitored in the 2-week period, particularly at 7 to 10 days, following initiation of fosaprepitant with each chemotherapy cycle.
Bei Patienten iwwer chronesch Warfarin-Therapie sollten d'INR eng optesch Iwwerwaachung an der 2-Wochenzäit, virun allem bei 7 bis 10 Deeg, no Initiativ vu fosaprepitant mat all Chemotherapie-Zyklus.